Contribution: Industrial Research Assistance Program – Contributions to Firms
Qualisure Diagnostics Inc.
$200,000.00
Innovate Molecular Decoder platform
FY 2025-26 · 2025-07-01
Summary
Develop and Scale the firm's Molecular deCoder™ (MDR) Precision Clinical Diagnostics Platform into an open platform to support the firm's Proprietary Precision Oncology diagnostic tests in development and to empower third-party clinical diagnostics developers to use the Firm's platform to advance AI-driven Precision Oncology-based solutions for clinical guidance and decision-making.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Calgary|Calgary, Alberta, Canada
Recipient Type
For-profit organization
Business Number
753382282
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2026-06-30
Agreement Number
1034631
Agreement Start Date
2025-07-01
Agreement Title
Innovate Molecular Decoder platform
Agreement Title (French)
Innover la plateforme de décodage moléculaire
Agreement Type
Contribution
Agreement Value
$200,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Develop and Scale the firm's Molecular deCoder™ (MDR) Precision Clinical Diagnostics Platform into an open platform to support the firm's Proprietary Precision Oncology diagnostic tests in development and to empower third-party clinical diagnostics developers to use the Firm's platform to advance AI-driven Precision Oncology-based solutions for clinical guidance and decision-making.
Description (French)
Développer et mettre à l’échelle la plateforme de diagnostic clinique de précision Molecular deCoder™ (MDR) de l’entreprise en une plateforme ouverte pour soutenir les tests de diagnostic d’oncologie de précision propriétaires de l’entreprise en cours de développement et pour permettre aux développeurs de diagnostics cliniques tiers d’utiliser la plateforme de l’entreprise pour faire progresser les solutions basées sur l’IA en oncologie de précision pour l’orientation clinique et la prise de décision.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Calgary Confederation
Federal Riding (French)
Calgary Confederation
Federal Riding Number
48005
NAICS Code
6215
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
753382282
Recipient City
Calgary|Calgary
Recipient Country
CA
Recipient Legal Name
Qualisure Diagnostics Inc.
Recipient Operating Name
Qualisure Diagnostics Inc.
Recipient Postal Code
T2L 1Y8
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2025-2026-Q2-1034631
